BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 6801980)

  • 1. Oral contraceptives, clotting factors, and thrombosis.
    Meade TW
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):758-61. PubMed ID: 6801980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease.
    Kelleher CC
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):392-5. PubMed ID: 2196811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and mechanisms of cardiovascular events in users of oral contraceptives.
    Meade TW
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1646-52. PubMed ID: 3287935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic changes and the oral contraceptive pill.
    Norris LA; Bonnar J
    Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):545-64. PubMed ID: 9488791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and anticoagulation effects of contraceptive steroids.
    Samsioe G
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1523-7. PubMed ID: 8178901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive choices in women with coagulation disorders.
    Comp PC; Zacur HA
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraception and coagulation.
    Notelovitz M
    Clin Obstet Gynecol; 1985 Mar; 28(1):73-83. PubMed ID: 3987135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives, blood clotting and thrombosis.
    Poller L
    Br Med Bull; 1978 May; 34(2):151-6. PubMed ID: 350338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and vascular disease.
    Sartwell PE; Stolley PD
    Epidemiol Rev; 1982; 4():95-109. PubMed ID: 6754411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
    Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
    Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.
    Winkler UH
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S51-61. PubMed ID: 9753311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
    Mann JI
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative status and oral contraceptive. Its relevance to platelet abnormalities and cardiovascular risk.
    Ciavatti M; Renaud S
    Free Radic Biol Med; 1991; 10(5):325-38. PubMed ID: 1855673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG
    Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral contraceptives on hemostasis and thrombosis.
    Rosing J; Tans G
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.